The Sclerotherapy of Primary Varicose Veins in Lower Extremity

ABSTRACT

In the early period (B.C.) the definition of the primary varicose vein in lower extremity was dilated, tortuous and elongated vein. The care of varicose vein is directed toward ablation of pathologic vessels. This is achieved by removing them surgically or by obliterating them with sclerotherapy. The sclerosing agents first used, however, were too strong to be used successfully for the treatment of such veins. The introduction of less toxic sclerosing agents now makes it possible to treat varicose vein safely, reliably, and easily. PURPOSE: We has been tried the clinical reserch because of good result & possibility of therapy by only sclerotherpy in well defined selected indication of primary varicose vein. METHOD: We reviewed primary varicose vein involved in lower extremity of 463 cases that was well treated by sclerosing agents to Dept of Surg, Kangbuk Samsung Hosp, SungKyunKwan University College of Medicine, From January 1996 To December 2000. RESULT: 1. The distribution of the age were the first, 4th decade (40.2%), followed by 5th decade, 3th decade. The ratio of sex were more prevalent in female than male (110). 2. Sx & sign were showed cosmetic problem (60.5%) in most patients, followed by pain (18.8%), swelling (9.3%), Heaviness (7.1%). 3. The duration of illness were over 5 yrs in most patient 373 cases (80.6%). 4. The associating factor were correlated with pregnancy in most female (33.7%), others were family Hx (7.8%), long standing posture, DM, HTN, Trauma. 5. The size of varicose vein were type II in case 312 (67.4%), followed by type III (27.4%), type I (4.1%), type IV (1.1%) according to the classification by Dr. Weiss. 6. The frequency of injection were 2~4 injection (68.3%) in most patient. During 4months of injection therapy, almost varicose veins were disppeared (91.4%). 7. Post injection complication were thrombosis in 38 cases, followed by hyperpigmentation in 25 cases, necrosis in 8 cases. 8. Recurrence rate after injection were extremely rare (6 cases). CONCLUSION: The sclerotherapy of telangiectasia (type I, II) is highly effective. The treatment based on knowledge of venous anatomy, selection of sclerosing agents is highly likely to be successful.